0.51
-0.001(-0.20%)
Currency In USD
| Previous Close | 0.51 |
| Open | 0.51 |
| Day High | 0.53 |
| Day Low | 0.48 |
| 52-Week High | 1.42 |
| 52-Week Low | 0.45 |
| Volume | 2.74M |
| Average Volume | 2.11M |
| Market Cap | 74.49M |
| PE | -2.42 |
| EPS | -0.21 |
| Moving Average 50 Days | 0.53 |
| Moving Average 200 Days | 0.67 |
| Change | -0 |
If you invested $1000 in Veru Inc. (VERU) since IPO date, it would be worth $217.18 as of May 31, 2025 at a share price of $0.508. Whereas If you bought $1000 worth of Veru Inc. (VERU) shares 4 years ago, it would be worth $140 as of May 31, 2025 at a share price of $0.508.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Veru Participates in a Virtual Investor KOL Connect Segment
GlobeNewswire Inc.
May 08, 2025 1:25 PM GMT
-- Moderated discussion with preeminent obesity expert, Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder, of Veru -- MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical sta
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
GlobeNewswire Inc.
May 01, 2025 12:30 PM GMT
MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will hos
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
GlobeNewswire Inc.
Apr 16, 2025 12:30 PM GMT
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that